Views 581
Citations 0
Editor's Note
November 2015

Global Drug Safety Insights From Taiwan

Author Affiliations

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2015;175(11):1847. doi:10.1001/jamainternmed.2015.5402

The investments made by the government of Taiwan to create the Taiwan National Health Insurance Research Database continue to realize global population health benefits. The database has been used to conduct numerous studies of drug safety and efficacy, diagnostic test utility, disease progression, and risk factor prognosis, generating important clinical and public health insights that have implications not only for the people of Taiwan but also for people around the world.1 The article by Lee et al2 on fluoroquinolone safety in this issue of JAMA Internal Medicine adds to this knowledge.

First Page Preview View Large
First page PDF preview
First page PDF preview